Foundation for innovation
in Cardiometabolism and Nutrition

Research

  • MASLD: An International Study Evaluates Noninvasive Biomarkers for HASH and Fibrosis

    MASLD: An International Study Evaluates Noninvasive Biomarkers for HASH and Fibrosis

  • ICAN IHU Renewal: Discover Our 2026–2030 Scientific Strategy

    ICAN IHU Renewal: Discover Our 2026–2030 Scientific Strategy

  • Neuder Law: France Adopts a National Strategy for the Prevention of Cardiovascular and Neurological Diseases

    Neuder Law: France Adopts a National Strategy for the Prevention of Cardiovascular and Neurological Diseases

  • The Cardiometabolic Continuum: 10 Major Scientific Publications That Advance Research

    The Cardiometabolic Continuum: 10 Major Scientific Publications That Advance Research

  • A major breakthrough in understanding the mechanisms of atrial cardiomyopathy

    A major breakthrough in understanding the mechanisms of atrial cardiomyopathy

  • IHU ICAN’s 2026 Scientific Conference: Discover the Award Winners’ Research Projects!

    IHU ICAN’s 2026 Scientific Conference: Discover the Award Winners’ Research Projects!

  • General practitioners: Help with the early screening of patients at risk for metabolic fatty liver disease (GRIPonMASH project)

    General practitioners: Help with the early screening of patients at risk for metabolic fatty liver disease (GRIPonMASH project)

  • Cardiovascular-kidney-metabolic (CKM): Toward a more integrated approach to cardiometabolic diseases

    Cardiovascular-kidney-metabolic (CKM): Toward a more integrated approach to cardiometabolic diseases

  • ANNITIA Data Challenge: Using AI to Better Predict the Progression of Non-Alcoholic Fatty Liver Disease

    ANNITIA Data Challenge: Using AI to Better Predict the Progression of Non-Alcoholic Fatty Liver Disease

  • The women driving cardiometabolic research forward at the IHU ICAN

    The women driving cardiometabolic research forward at the IHU ICAN

ISO 9001 Certified

OUr Institutionnal Supporters

Our network